
Hepatitis B virus infection and the risk of liver disease progression in type 2 diabetic patients with potential nonalcoholic fatty liver disease: a retrospective, observational, cohort study in the United Kingdom Clinical Practice Research Datalink
Author(s) -
Germano Ferreira,
Anke L. Stuurman,
Yves Horsmans,
Tom Cattaert,
Thomas Verstraeten,
Feng Yang,
Dominique Rosillon,
Adrienne Guignard
Publication year - 2020
Publication title -
european journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.881
H-Index - 102
eISSN - 1473-5687
pISSN - 0954-691X
DOI - 10.1097/meg.0000000000001537
Subject(s) - medicine , nonalcoholic fatty liver disease , cohort , cirrhosis , type 2 diabetes mellitus , hepatocellular carcinoma , gastroenterology , retrospective cohort study , liver disease , hepatitis c , hepatitis b virus , cohort study , fatty liver , diabetes mellitus , disease , immunology , virus , endocrinology
Assess the risk of progression to cirrhosis and hepatocellular carcinoma (HCC) due to hepatitis B virus (HBV)-infection in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM).